Provided by Tiger Trade Technology Pte. Ltd.

Cognition Therapeutics, Inc

1.05
+0.04003.96%
Pre-market: 1.03-0.0237-2.26%05:26 EDT
Volume:377.80K
Turnover:393.29K
Market Cap:99.85M
PE:-5.42
High:1.07
Open:1.01
Low:1.01
Close:1.01
52wk High:2.67
52wk Low:0.5501
Shares:95.09M
Float Shares:85.42M
Volume Ratio:1.10
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1936
EPS(LYR):-0.3228
ROE:-83.76%
ROA:-78.18%
PB:3.02
PE(LYR):-3.25

Loading ...

Mar 30, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2022

Major Issues Report

8-K - Current report
Feb 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 10, 2022

Major Issues Report

8-K - Current report
Nov 18, 2021

Major Issues Report

8-K - Current report
Nov 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Major Issues Report

8-K - Current report
Nov 02, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 25, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Oct 14, 2021

Major Issues Report

8-K - Current report
Oct 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 04, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 10, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 20, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 29, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 29, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 29, 2021

Correspondence

CORRESP [Cover] - Correspondence